The “red herring” after 20 years: ageing and health care expenditures Friedrich BreyerNormann Lorenz Editorial Open access 04 June 2020 Pages: 661 - 667
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland Michaela Carla BarbierEsther Pardofor the Swiss Group for Clinical Cancer Research (SAKK) Original Paper Open access 21 March 2021 Pages: 669 - 677
Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others Sebastian Neumann-BöhmeStefan A. LipmanArthur E. Attema Original Paper Open access 20 March 2021 Pages: 679 - 697
How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach Shuli Brammli-GreenbergIra YaariAriella Adijes-Toren Original Paper 23 March 2021 Pages: 699 - 709
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses Mark OppeDaniela Ortín-SulbaránJuan M. Ramos-Goñi Original Paper Open access 20 April 2021 Pages: 711 - 721
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists Michael J. ZorattiA. Simon PickardHealth Utility Book (HUB) Working Group Original Paper 11 April 2021 Pages: 723 - 733
Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients Asrul Akmal ShafieIrwinder Kaur ChhabraNoor Syahireen Mohammed Original Paper 15 April 2021 Pages: 735 - 747
Are long-term care jobs harmful? Evidence from Germany Thomas RappJérôme RonchettiJonathan Sicsic Original Paper 11 April 2021 Pages: 749 - 771
Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates Samer A. KharroubiYara Beyh Original Paper 24 March 2021 Pages: 773 - 788
Has the development of cancer biomarkers to guide treatment improved health outcomes? Ana Beatriz D′Avó LuísMikyung Kelly Seo Original Paper Open access 30 March 2021 Pages: 789 - 810
Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices Jean SpinksSon NghiemJoshua Byrnes Original Paper 10 April 2021 Pages: 811 - 831
The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach Karina DietermannVera WinterJonas Schreyögg Original Paper Open access 19 April 2021 Pages: 833 - 846
Correction to: A general framework for classifying costing methods for economic evaluation of health care Zuzana ŠpacírováDavid EpsteinJaime Espín Correction Open access 25 May 2021 Pages: 847 - 847
Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease L. M. Peña-LongobardoB. Rodríguez-SánchezJ. López-Bastida Correction Open access 25 May 2021 Pages: 849 - 849
